BofA upgraded Bristol Myers (BMY) to Buy from Neutral with a price target of $61, up from $52.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- PayPal, SoundHound, Moderna, Devon, Bristol-Myers: Trending by Analysts
- Midday Fly By: Broadcom slides, pot stocks jump
- Roblox downgraded, Lululemon upgraded: Wall Street’s top analyst calls
- Arcus Biosciences Stock (RCUS) Collapses 17% after Failed Stomach Cancer Study
- Bristol Myers price target raised to $37 from $36 at Morgan Stanley